News | May 06, 2007

FDA Clears Hansen’s Robotic EP Mapping Technology

May 7, 2007 — Hansen Medical Inc. has announced it has obtained FDA clearance for commercialization of the Sensei Robotic Catheter System and Artisan Control Catheter to facilitate manipulation, positioning and control of mapping catheters during electrophysiology (EP) procedures.

The clearance allows physicians to use Hansen Medical's first generation robotic platform to easily place mapping catheters in hard-to-reach anatomical locations within the heart and maintain catheter stability during the diagnostic phase of complex cardiac arrhythmia treatment. Physicians who have used this product for EP procedures say the Sensei system has the potential to change the way cardiac procedures are performed to a more standard approach for complex diseases.

Andrea Natale, M.D., director for the Center for Atrial Fibrillation, director of the Electrophysiology Laboratories and head of the Section of Pacing and Electrophysiology at the Cleveland Clinic Foundation, used the Sensei system during clinical evaluation on 25 patients in the Czech Republic and Germany.

"The stability of the Artisan catheter allowed us to perform catheter mapping procedures more efficiently and effectively," said Dr. Natale. "Moreover, the incorporation of the new Sensei system and catheter did not add time to the procedures, nor did it require increased radiation time, as would normally be expected with new technology. As a result, I would expect this new system to become the medical standard for performing complex EP procedures, which are currently limited to those individuals with the highest level of skill."

The new robotic catheter system is compatible with fluoroscopy, ultrasound, 3D surface map and patient electrocardiogram data. The two main components that comprise the system are the Artisan control catheter and an ergonomically designed, remotely placed workstation where the physician is seated throughout each procedure. In addition to lessening operator fatigue, the remote workstation creates a virtual shield for physicians against harmful radiation.

The open architecture provided by the Sensei System, which allows the use of pre-approved catheters from third-party manufacturers, requires a labeling addition from the FDA. The addition is intended to remind physicians that the safety and effectiveness of the system for use with cardiac ablation catheters in the treatment of cardiac arrhythmias, including atrial fibrillation, have not been established.

For more information visit www.hansenmedical.com.

Related Content

Abbott Announces European Launch of Advisor HD Grid Mapping Catheter, Sensor Enabled
Technology | EP Mapping and Imaging Systems| January 19, 2018
Abbott last week announced CE Mark approval for the company's new Advisor HD Grid Mapping Catheter, Sensor Enabled, a...
Videos | EP Mapping and Imaging Systems| October 24, 2017
This video, provided by Acutus Medical, demonstrates a patient case showing the use of the AcQMap high-resolution ele
Acutus Medical Receives FDA Clearance for AcQMap Cardiac Mapping Technology
Technology | EP Mapping and Imaging Systems| October 24, 2017
Acutus Medical announced that the U.S. Food and Drug Administration (FDA) has cleared the AcQMap High Resolution...
Acutus Medical Announces Completion of Enrollment for UNCOVER AF Study
News | EP Mapping and Imaging Systems| May 02, 2017
Acutus Medical recently announced that enrollment has been completed in its pivotal Utilizing Novel Dipole Density...
Videos | EP Mapping and Imaging Systems| February 01, 2017
This video, provided by Medtronic, demonstrates the CardioInsight electro-anatomical mapping system.
medtronic cardioinsight electromapping system, electoanatomical mapping, noninvasive ep mapping

A screen shot of the waveforms and the the 3-D electo-mapping models created using the noninvasive CardioInsight system.

Technology | EP Mapping and Imaging Systems| February 01, 2017
February 1, 2017 — Medtronic received U.S.
BioSig Technologies, Pure EP system, JACC Clinical Electrophysiology, Journal of the American College of Cardiology, Purkinje Network
News | EP Mapping and Imaging Systems| January 16, 2017
January 16, 2017 — BioSig Technologies Inc. announced that the company’s Pure EP System, a novel cardiac...
St. Jude Medical, EnSite Precision cardiac mapping system, FDA clearance, catheter ablation
Technology | EP Mapping and Imaging Systems| January 03, 2017
St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) clearance of its EnSite Precision™ cardiac...
Acutus Medical, AcQMap High Resolution Imaging and Mapping System, atrial fibrillation, UNCOVER-AF trial, first procedure
News | EP Mapping and Imaging Systems| October 27, 2016
Acutus Medical announced the completion of the first patient procedure in the “Utilizing Novel Dipole Density...
St. Jude Medical, Ensite Precision cardiac mapping system, full European market release
News | EP Mapping and Imaging Systems| October 06, 2016
St. Jude Medical Inc. announced a full market release of its EnSite Precision cardiac mapping system and new Sensor...
Overlay Init